News
FDA Expands Gene Therapy for Younger Patients
1+ hour, 25+ min ago (331+ words) Conexiant The US Food and Drug Administration has approved an expanded indication for exagamglogene autotemcel (CASGEVY) to include patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia, according to a press release…...
ASCO26: Alicia Morgans, MD, MPH, ARACOG
1+ day, 9+ hour ago (53+ words) Conexiant Video Player is loading. Play Video Play Skip Backward Skip Forward Mute Current Time 0: 00/Duration -: -Loaded: 0%Stream Type LIVESeek to live, currently behind live LIVERemaining Time -0: 00 1x Playback Rate Chapters Chapters Descriptionsdescriptions off, selected Captionscaptions settings, opens captions settings dialogcaptions…...
PTSD May Be Linked to Accelerated Aging
13+ hour, 20+ min ago (317+ words) Conexiant Patients with posttraumatic stress disorder may exhibit coordinated molecular changes involving redox metabolism, neuronal signaling, immune activation, and accelerated biological aging Researchers identified distinct plasma protein and metabolite signatures associated with chronic posttraumatic stress disorder In a study, they…...
ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer
13+ hour, 52+ min ago (61+ words) Conexiant ASCO26: Julia Rotow, MD, Silevertinib in Lung Cancer Dana-Farber Cancer Institute's Dr. Julia Rotow reported on a study looking at silevertinib, with data showing it may offer a new first-line option for hard-to-treat EGFR non-small cell lung cancer variants, with…...
ASCO26: David Reardon, MD, Glioblastoma Vaccine
14+ hour, 22+ min ago (51+ words) Conexiant ASCO26: David Reardon, MD, Glioblastoma Vaccine Dana-Farber Cancer Institute's Dr. David Reardon reports on data showing a phase 1 trial looking at a personalized vaccine plus pembrolizumab sparked tumor-targeting T cells in glioblastoma and was linked to longer survival in immune…...
ASCO26: Jennifer Ligibel, MD, BWEL
17+ hour, 41+ min ago (49+ words) Conexiant ASCO26: Jennifer Ligibel, MD, BWEL Dana-Farber Cancer Institute's Dr. Jennifer Ligibel shared updated results from the BWEL study showing a weight loss intervention led to significantly better physical function, global physical and mental health, and symptom in patients with early…...
ASCO26: Atish Choudhury, MD, Ph D, A-DREAM/Alliance A032101
18+ hour, 44+ min ago (58+ words) Conexiant ASCO26: Atish Choudhury, MD, Ph D, A-DREAM/Alliance A032101 A-DREAM/Alliance A032101 study presented by Dana-Farber Cancer Institute's Dr. Atish Choudhury shows 41% of favorable responders to testosterone suppression plus androgen receptor pathway inhibitor remaining treatment-free with testosterone recovery at 18 months after treatment…...
FDA Approves Treg Cell Therapy
21+ hour, 23+ min ago (173+ words) A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers. The US Food and Drug Administration has approved Tregzi, the first regulatory T-cell-based immunotherapy indicated…...
AI Tool Finds More Long COVID Cases Than Codes
2+ day, 4+ hour ago (482+ words) Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-Co V-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management. An artificial intelligence'enabled electronic health record phenotyping approach identified patients meeting criteria for postacute sequelae…...
STOPGAP II " a national randomized clinical trial for patients with stage 4 gastric cancer
2+ day, 10+ hour ago (150+ words) Conexiant What starts at UCI Health can help shape the national conversation. At ASCO 2026, Maheswari Senthil, MD, chief of surgical oncology, discussed STOPGAP II " a national randomized clinical trial for patients with stage 4 gastric cancer and peritoneal carcinomatosis. The trial…...